Vitamin K2 Market Trends

Growth Drivers

• Increase in cases of osteoporosis: Epidemiological studies suggest that vitamin K2 deficiency is related to osteoporosis. According to the International Osteoporosis Foundation, currently, 1 in 3 women and 1 in 5 men over the age of 50 globally, are suffering from bone diseases, such as osteoporosis. The daily recommended vitamin K2 intake for adult women is 90 mcg, however, higher doses may be required for optimal bone health. The rising cases of osteoporosis are augmenting the market expansion in the assessed period.
• Rising heart disease: Vitamin K2 helps reduce the risk of heart disease by regulating calcium homeostasis. Doctors are emphasizing on intake of vitamin K2 to increase cardiac output and decrease blood lactate. According to the National Institutes of Health, cardiovascular diseases are the leading cause of mortality. The report further states that in 2022, 702,880 people died from heart disease, which is equivalent to 1 in every 5 deaths.
• Efficient in fighting against cancer: Various studies suggest that vitamin K2 has been shown significant anticancer activities. It has been found to induce apoptosis in the cells of cancer. According to the World Health Organization, in 2022, there were an estimated 20 million new cancer cases and 9.7 million deaths. Due to the therapeutic effects of taking vitamin K on cancer, the demand for vitamin K in the form of powder or oil is rising globally.

Challenges

• Issues related to expiry dates: Medicines and supplements have a shelf life of almost 2 years. If the supplement is not being consumed in a certain period, then it becomes hazardous for health which can cause serious health problems in the future. This factor is expected to prompt the consumer to buy less vitamin K2 for consumption.